cbdMD, Inc.·4

Oct 1, 5:02 PM ET

Kennedy Thomas Ronan 4

4 · cbdMD, Inc. · Filed Oct 1, 2020

Insider Transaction Report

Form 4
Period: 2020-10-01
Kennedy Thomas Ronan
DirectorCEO and CFO
Transactions
  • Award

    Stock option

    2020-10-01+33,33333,333 total
    Exercise: $3.50From: 2022-10-01Exp: 2027-10-01Common stock (33,333 underlying)
  • Award

    Stock option

    2020-10-01+41,66741,667 total
    Exercise: $5.00From: 2022-10-01Exp: 2027-10-01Common stock (41,667 underlying)
  • Award

    Stock option

    2020-10-01+41,66641,666 total
    Exercise: $5.00From: 2023-10-01Exp: 2028-10-01Common stock (41,666 underlying)
  • Award

    Stock option

    2020-10-01+41,66741,667 total
    Exercise: $6.50From: 2022-10-01Exp: 2027-10-01Common stock (41,667 underlying)
  • Award

    Restricted stock award

    2020-10-01+16,66616,666 total
    Exercise: $0.00From: 2023-10-01Exp: 2023-10-01Common stock (16,666 underlying)
  • Award

    Stock option

    2020-10-01+33,33333,333 total
    Exercise: $3.50From: 2023-10-01Exp: 2028-10-01Common stock (33,333 underlying)
  • Award

    Restricted stock award

    2020-10-01+16,66716,667 total
    Exercise: $0.00From: 2021-10-01Exp: 2021-10-01Common stock (16,667 underlying)
  • Award

    Stock option

    2020-10-01+33,33433,334 total
    Exercise: $3.50From: 2021-10-01Exp: 2026-10-01Common stock (33,334 underlying)
  • Award

    Restricted stock award

    2020-10-01+16,66716,667 total
    Exercise: $0.00From: 2022-10-01Exp: 2022-10-01Common stock (16,667 underlying)
  • Award

    Stock option

    2020-10-01+41,66741,667 total
    Exercise: $5.00From: 2021-10-01Exp: 2026-10-01Common stock (41,667 underlying)
  • Award

    Stock option

    2020-10-01+41,66741,667 total
    Exercise: $6.50From: 2021-10-01Exp: 2026-10-01Common stock (41,667 underlying)
  • Award

    Stock option

    2020-10-01+41,66641,666 total
    Exercise: $6.50From: 2023-10-01Exp: 2028-10-01Common stock (41,666 underlying)
Footnotes (4)
  • [F1]Restricted stock award ("RSA") granted under the Issuer's 2015 Equity Compensation Plan (the "Plan") pursuant to the terms of the Executive Employment Agreement dated September 15, 2020, with an effective date of October 1, 2020 (the "Employment Agreement") by and between the Issuer and the Reporting Person. Each RSA represents the right to receive one share of the Issuer's common stock on October 1, 2021 provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.
  • [F2]RSA granted under the Plan pursuant to the terms of the Employment Agreement. Each RSA represents the right to receive one share of the Issuer's common stock on October 1, 2022 provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.
  • [F3]RSA granted under the Plan pursuant to the terms of the Employment Agreement. Each RSA represents the right to receive one share of the Issuer's common stock on October 1, 2023 provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.
  • [F4]Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

Documents

1 file
  • 4
    section16.xmlPrimary

    PRIMARY DOCUMENT